揭开新型PROTACs的秘密,以提高降解效率
Juan Huang1, Xiaoyan Yang2, Qiuqian Huang2
1School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, Guizhou, People's Republic of China.
Molecular diversity
|July 5, 2025
概括
新型蛋白质分解向金马 (PROTACs) 提高了对具有挑战性的目标的降解效率. 本综述探讨了提高PROTAC疗效背后的机制,帮助未来的药物设计.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的抑制剂面临着局限性,特别是对于"不可抗药"的标和耐药性.
- 化向化体 (PROTACs) 通过诱导蛋白降解,提供了一个有前途的替代方案.
- 对于药理学成功而言,PROTAC降解效率至关重要,它推动了研究新策略的研究.
研究的目的:
- 综合探索新型PROTAC并阐明增强降解效率的机制.
- 分析影响PROTAC降解活动的因素.
- 将新型的 PROTAC 与传统的对应物进行比较,并通过成功的案例研究验证发现.
主要方法:
- 对现有的PROTAC研究进行了深入分析.
- 识别和描述影响PROTAC降解的变量.
- 对新型与传统的PROTAC进行比较分析.
- 利用成功的案例研究来验证理论框架.
主要成果:
- 新的PROTAC设计与传统设计相比,具有更好的降解效率.
- 特定的分子设计元素和机制有助于增强PROTAC活动.
- 成功的应用证明了改善PROTAC降解的策略的有效性.
结论:
- 了解增强降解的机制是设计强大的PROTACs的关键.
- 这项工作为未来的 PROTAC 开发和优化提供了洞察力.
- 新型PROTACs在准难以实现的蛋白质和克服抗性方面取得了重大进展.
相关概念视频
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
The Proteasome
9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
Prodrugs
3.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.0K
The Proteasome Structure
987
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
987


